Depending on how one views it, the stock price performance for the year has been a mixed bag, resulting in either an optimistic or pessimistic outlook. Year to date metric has recorded a gain of 371.24%.However, over the last six months, we can see a weaker performance of 124.92%. Over the last 30 days, the price of ADMA has fallen by 35.76%. And in the last five days, it has surged by 5.45%.
Adma Biologics Inc ‘s stock market performance has been somewhat predictable. The company’s stock reached a 1-year high price of $23.64 on 11/11/24, while the lowest value for the same period was recorded at $3.60 on 12/12/23.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
52-week price history of ADMA Stock
Examining the 52-week high and low prices can provide valuable insights into a stock’s current status and future performance. Adma Biologics Inc’s current trading price is -9.90% away from its 52-week high, while its distance from the 52-week low is 491.67%. The stock’s price range during this time has been between $3.60 and $23.64. The trading volume for the Healthcare sector company’s shares reached about 2.19 million for the day, which was lower than the average daily volume of 5.14 million over the last three months.
Market Capitalization vs. Financial Performance: A Comparative Study
Adma Biologics Inc (ADMA) has experienced a quarterly rise of 15.76% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 5.04B and boasts a workforce of 624 employees.
Combining Moving Average and Trading Volume Data for Better Market Insight
Based on Barchart.com data, the company’s moving average over the 100-day period was 16.80, with a change in price of +9.90. Similarly, Adma Biologics Inc recorded 4,652,685 in trading volume during the last 100 days, posting a change of +86.84%.
ADMA’s Debt-to-Equity Ratio Cause for Concern? An In-Depth Look
The debt-to-equity (D/E) ratio is a significant metric that provides insights into a company’s financial state and market presence. By dividing a company’s current liabilities by its shareholders’ equity, the D/E ratio depicts the extent of debt used by a company to fund its assets relative to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for ADMA stands at 0.48. Similarly, the long-term debt-to-equity ratio is also 0.48.
ADMA Stock Stochastic Average
Today, Adma Biologics Inc’s raw stochastic average for the past 50 days stands at 71.84%, indicating a rise from the raw stochastic average of the last 20 days, which was 70.29%. Moreover, the company’s Stochastic %K and %D values over the past 20 days were 68.54% and 61.16% respectively.
